Prediction and prevention of early-onset pre-eclampsia: Impact of aspirin after first-trimester screening

Ultrasound in Obstetrics and Gynecology

Volumn 46, Issue 4, 2015, Pages 419-423

  Park, F ^a,b   Russo, K ^a   Williams, P ^a,b   Pelosi, M ^b   Puddephatt, R ^b   Walter, M ^b   Leung, C ^a   Saaid, R ^b,c   Rawashdeh, H ^b   Ogle, R ^b   Hyett, J ^a,b  

^a University of Sydney   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

a spirin; first trimester prediction; mean arterial pressure; PAPP A; pre eclampsia; uterine artery Doppler

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AUSTRALIA; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; NEWBORN; PRE-ECLAMPSIA; PREDICTIVE VALUE; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; PULSED DOPPLER ULTRASONOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ASPIRIN; AUSTRALIA; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, PULSED;

EID: 84942992019     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14819     Document Type: Article

References (31)

1. Sibai B, Dekker G, Kupferminc M,. Pre-eclampsia. Lancet 2005; 365: 785-799.
2. Khan KS, Wojdyla D, Say L, Gu lmezoglu AM, Van Look PFA,. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-1074.
3. Sibai BM,. What to expect from expectant management in severe preeclampsia at <34 weeks gestation: pregnancy outcomes in developed vs developing countries. Am J Obstet Gynecol 2013; 209: 400-401.
4. Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH,. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 2012; 32: 171-178.
5. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH,. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.
6. Park FJ, Leung CH, Poon LC, Williams PF, Rothwell SJ, Hyett JA,. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust NZ J Obstet Gynaecol 2013; 53: 532-539.
7. Scazzocchio E, Figueras F, Crispi F, Meler E, Masoller N, Mula R, Gratacos E,. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol 2013; 208: 203.e1-203.e10.
8. Baschat AA, Magder LS, Doyle LE, Atlas RO, Jenkins CB, Blitzer MG,. Prediction of preeclampsia utilizing the first trimester screening examination. Am J Obstet Gynecol 2014; 211: 514.e1-7.
9. Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH,. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn 2010; 30: 216-223.
10. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy. Lancet 1993; 341: 396-400.
11. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M,. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993; 329: 1213-1218.
12. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994; 343: 619-629.
13. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G,. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998; 338: 701-705.
14. Golding J., A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. Br J Obstet Gynaecol 1998; 105: 293-299.
15. Yu CK, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH,. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003; 22: 233-239.
16. Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E,. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141-146.
17. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E,. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013; 41: 491-499.
18. National Institute for Health and Clinical Excellence clinical guideline 107. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy, 2010; www.nice.org.uk/guidance/CG107.
19. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia, 2011; http://whqlibdoc.who.int/publications/2011/9789241548335-eng.pdf.
20. Brown MA, Lindheimer MD, de Swiet SM, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: 9-14.
21. Beaufils M, Uzan S, Donsimoni R, Colau JC,. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 1: 840-842.
22. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P,. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1-3.
23. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA,; PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791-1798.
24. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y,. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414.
25. Brosens I, Pijnenborg R, Vercruysse L, Romero R,. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011; 204: 193-201.
26. Nelson DB, Ziadie MS, McIntire DD, Rogers BB, Leveno KJ,. Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol 2014; 210: 66.e1-7.
27. Nicolaides KH,. The ASPRE study: Combined multi-marker screening and randomised patient treatment with ASpirin for evidence-based PRE-eclampsia prevention. Registry No. ISRCTN13633058. http://www.controlled02010;trials.com/ISRCTN13633058.
28. Caron N, Rivard GE, Michon N, Morin F, Pilon D, Moutquin JM, Rey E,. Low-dose ASA response using the PFA-100 in women with high-risk pregnancy. J Obstet Gynaecol Can 2009; 31: 1022-1027.
29. Dumont A, Flahault A, Beaufils M, Verdy E, Uzan S,. Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 1999; 180: 135-140.
30. Hermida RC, Ayala DE, Fernández JR, Mojõn A, Alonso I, Silva I, Ucieda R, Codesido J, Iglesías M,. Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 1999; 34: 1016-1023.
31. Ayala DE, Ucieda R, Hermida RC,. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 2013; 30: 260-279.